Ghrelin Gene Polymorphisms in Irritable Bowel Syndrome
Author(s) -
Theodora Kalli,
Tilemachos Koutouratsas,
George Karamanolis,
Maria Gazouli
Publication year - 2020
Publication title -
digestion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.882
H-Index - 75
eISSN - 1421-9867
pISSN - 0012-2823
DOI - 10.1159/000506306
Subject(s) - irritable bowel syndrome , genotype , gastroenterology , ghrelin , medicine , pathogenesis , genotyping , constipation , allele , allele frequency , polymorphism (computer science) , diarrhea , genotype frequency , endocrinology , hormone , biology , genetics , gene
Irritable bowel syndrome (IBS) is a bowel disorder characterized by pain accompanying defecation or altered bowel habits, divided into diarrhea-predominant, constipation-predominant, and alternating subtypes, whose pathogenesis is considered to include disordered bowel motility. The hormone ghrelin is a growth hormone secretagogue which furthermore affects gastrointestinal motility. We study the association between its genetic polymorphisms and the risk for IBS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom